- New disease site documented on MIBG scintigraphy; or CT/MRI; or any new bone site that is FDG-PET avid (in patient known to have MIBG non-avid tumor) AND has MRI findings consistent with tumor OR has a biopsy showing NB or ganglioneuroblastoma;